Continuous-infusion spirogermanium for the treatment of refractory carcinoma of the ovary: a phase II trial.
作者信息
Kavanagh J J, Saul P B, Copeland L J, Gershenson D M, Krakoff I H
出版信息
Cancer Treat Rep. 1985 Jan;69(1):139-40.
PMID:3967257
Abstract
摘要
相似文献
1
Continuous-infusion spirogermanium for the treatment of refractory carcinoma of the ovary: a phase II trial.
Cancer Treat Rep. 1985 Jan;69(1):139-40.
2
Phase II trial of spirogermanium in advanced epithelial carcinoma of the ovary.螺锗用于晚期卵巢上皮癌的II期试验。
Cancer Treat Rep. 1982 Aug;66(8):1675-6.
3
Phase II evaluation of spirogermanium in advanced ovarian carcinoma.螺锗在晚期卵巢癌中的II期评估。
Cancer Treat Rep. 1983 Feb;67(2):193-4.
4
Phase II study of spirogermanium in the treatment of metastatic breast cancer.
Cancer Treat Rep. 1984 Sep;68(9):1197-8.
5
Phase II trial of spirogermanium for treatment of advanced breast cancer.螺锗治疗晚期乳腺癌的II期试验。
Cancer Treat Rep. 1983 Feb;67(2):189-90.
6
Phase II trial of spirogermanium in breast adenocarcinoma: a Cancer and Leukemia Group B Study.螺锗治疗乳腺腺癌的II期试验：一项癌症与白血病B组研究
Cancer Treat Rep. 1982 Aug;66(8):1667-8.
7
Phase II Eastern Cooperative Oncology Group Study of spirogermanium in previously treated lymphoma.
Cancer Treat Rep. 1986 Jul;70(7):917-8.
8
Phase I trial of spirogermanium given by infusion in a multiple-dose schedule.按多剂量方案静脉输注螺锗的I期试验。
Cancer Treat Rep. 1982 Jan;66(1):173-5.
9
[Metastatic cancer of the prostate: phase II study of spirogermanium (NSC 192965)].
Bull Cancer. 1986;73(1):65-7.
10
Phase II study of spirogermanium in patients with advanced carcinoma of the cervix.螺锗用于晚期宫颈癌患者的II期研究。
Cancer Treat Rep. 1985 Apr;69(4):457-8.
引用本文的文献
1
Complexes of metals other than platinum as antitumour agents.除铂之外的金属配合物作为抗肿瘤剂。
Eur J Clin Pharmacol. 1994;47(1):1-16. doi: 10.1007/BF00193472.
2
Nephrotoxicity and neurotoxicity in humans from organogermanium compounds and germanium dioxide.有机锗化合物和二氧化锗对人体的肾毒性和神经毒性。
Biol Trace Elem Res. 1991 Jun;29(3):267-80. doi: 10.1007/BF03032683.
Zotero 插件